Literature DB >> 29415187

Microarray is an efficient tool for circRNA profiling.

Shasha Li, Shuaishuai Teng, Junquan Xu, Guannan Su, Yu Zhang, Jianqing Zhao, Suwei Zhang, Haiyan Wang, Wenyan Qin, Zhi John Lu, Yong Guo, Qianyong Zhu, Dong Wang.   

Abstract

Circular RNAs (circRNAs) are emerging as a new class of endogenous and regulatory noncoding RNAs in latest years. With the widespread application of RNA sequencing (RNA-seq) technology and bioinformatics prediction, large numbers of circRNAs have been identified. However, at present, we lack a comprehensive characterization of all these circRNAs in interested samples. In this study, we integrated 87 935 circRNAs sequences that cover most of circRNAs identified till now represented in circBase to design microarray probes targeting back-splice site of each circRNA to profile expression of those circRNAs. By comparing the circRNA detection efficiency of RNA-seq with this circRNA microarray, we revealed that microarray is more efficient than RNA-seq for circRNA profiling. Then, we found ∼80 000 circRNAs were expressed in cervical tumors and matched normal tissues, and ∼25 000 of them were differently expressed. Notably, many of these circRNAs detected by this microarray can be validated by quantitative reverse transcription polymerase chain reaction (RT-qPCR) or RNA-seq. Strikingly, as many as ∼18 000 circRNAs could be robustly detected in cell-free plasma samples, and the expression of ∼2700 of them differed after surgery for tumor removal. Our findings provided a comprehensive and genome-wide characterization of circRNAs in paired normal tissues and tumors and plasma samples from multiple individuals. In addition, we also provide a rich resource with 41 microarray data sets and 10 RNA-seq data sets and strong evidences for circRNA expression in cervical cancer. In conclusion, circRNAs could be efficiently profiled by circRNA microarray to target their reported back-splice sites in interested samples.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cervical cancer; circRNA microarray; circRNAs; noninvasively biomarker; plasma circRNA

Mesh:

Substances:

Year:  2019        PMID: 29415187     DOI: 10.1093/bib/bby006

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  65 in total

Review 1.  Role of circular RNAs in brain development and CNS diseases.

Authors:  Suresh L Mehta; Robert J Dempsey; Raghu Vemuganti
Journal:  Prog Neurobiol       Date:  2020-01-10       Impact factor: 11.685

2.  Circ_0001247 functions as a miR-1270 sponge to accelerate cervical cancer progression by up-regulating ZEB2 expression level.

Authors:  Wenshuang Wang; Anli Xu; Manyin Zhao; Jianan Sun; Lingyun Gao
Journal:  Biotechnol Lett       Date:  2021-01-01       Impact factor: 2.461

Review 3.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

4.  Silencing CircEIF3I/miR-526b-5p Axis Epigenetically Targets HGF/c-Met Signal to Hinder the Malignant Growth, Metastasis and Angiogenesis of Hepatocellular Carcinoma.

Authors:  Yang Liu; Xia Xiao; Jingying Wang; Yitong Wang; Yanhui Yu
Journal:  Biochem Genet       Date:  2022-06-20       Impact factor: 1.890

5.  MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway.

Authors:  Dongliang Liu; Xiulan Ma
Journal:  Int J Med Sci       Date:  2021-07-11       Impact factor: 3.738

6.  Upregulated circRAD18 promotes tumor progression by reprogramming glucose metabolism in papillary thyroid cancer.

Authors:  Wenkuan Chen; Tingting Zhang; Yanfang Bai; Hong Deng; Fang Yang; Renjie Zhu; Yingle Chen; Zheng He; Qi Zeng; Ming Song
Journal:  Gland Surg       Date:  2021-08

7.  Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer.

Authors:  Yu-Tao Liu; Xiao-Hong Han; Pu-Yuan Xing; Xing-Sheng Hu; Xue-Zhi Hao; Yan Wang; Jun-Ling Li; Zhi-Shang Zhang; Zhi-Hao Yang; Yuan-Kai Shi
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

8.  circ0101675 promotes malignant process via sponging miR-1278 and upregulating WNT3A/5A in non-small cell lung cancer.

Authors:  Wei Du; Jianpeng Hu; Rong Hu; Min Yang; Yun Peng; Zhiwei Zhang; Yuehua Li; Xiusheng He
Journal:  J Cancer       Date:  2021-05-17       Impact factor: 4.207

Review 9.  Hints From the Cellular Functions to the Practical Outlook of Circular RNAs.

Authors:  Liora Yesharim; Marzieh Mojbafan; Maryam Abiri
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

10.  Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer.

Authors:  Wenkuan Chen; Jianchang Fu; Yingle Chen; Yudong Li; Li Ning; Dou Huang; Shumei Yan; Quan Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-21       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.